NCT05105932 is a clinical trial in Pulmonary Ventilation, sponsored by Peking Union Medical College Hospital.

Who is sponsoring NCT05105932?

NCT05105932 is sponsored by Peking Union Medical College Hospital.

What condition does NCT05105932 study?

NCT05105932 studies Pulmonary Ventilation, Pulmonary Perfusion.

Is NCT05105932 still recruiting?

NCT05105932 is currently status unknown. Last updated 3 November 2021.

Last reviewed 2021-11-03 · How we verify

NCT05105932

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Study of Regional Lung Ventilation-perfusion by EIT

Status unknown Last updated 3 November 2021

What this trial tests

trial in Pulmonary Ventilation in 100 participants. Status unknown.

Timeline

1 January 2020

Primary endpoint
1 June 2023

1 June 2023

Quick facts

Lead sponsor	Peking Union Medical College Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 January 2020
Primary completion	1 June 2023
Estimated completion	1 June 2023
Sites	1 location across China

Conditions studied

Pulmonary Ventilation — all drugs for Pulmonary Ventilation →
Pulmonary Perfusion — all drugs for Pulmonary Perfusion →

Sponsor

Peking Union Medical College Hospital

Who can join

Adults 18 to 80, any sex, with Pulmonary Ventilation or Pulmonary Perfusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective observational trial. The purpose of this study is to explore the feasibility of EIT monitoring pulmonary blood flow and the consistency and difference between EIT monitoring pulmonary local ventilation blood flow and SPECT and CTPA monitoring methods

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Peking Union Medical College Hospital trials

Trials by the same sponsor.

NCT07466251 — PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke · Phase 4 · not yet recruiting
NCT06743321 — Speech-to-speech Voice-cloning Care (SVCC) to Improve ICU-acquired Anxiety for Critically Ill Patients · NA · not yet recruiting
NCT07590336 — 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma · Phase 1, PHASE2 · not yet recruiting
NCT07515976 — Mapping of Genomic Structural Variations in Major Birth Defects · not yet recruiting
NCT07386756 — Early Precise Identification and Intervention Strategies for Individuals at High Risk of Prediabetes · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05105932 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking Union Medical College Hospital
Last refreshed: 3 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05105932.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing